Cancers of unknown primary site: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 18, Issue SUPPL. 2, 2007, Pages

  Briasoulis, E ^a,b   Pavlidis, N ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ESMO HEAD OFFICE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN RECEPTOR; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PLATINUM COMPLEX; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AXILLARY LYMPH NODE; BIOCHEMISTRY; BLOOD ANALYSIS; BONE METASTASIS; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INDIVIDUALIZATION; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; PATIENT CARE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; URINALYSIS;

HUMANS; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; RISK ASSESSMENT;

EID: 43749106407     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm049     Document Type: Article

References (4)

1. Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary, Eur J Cancer 2003; 39 (14): 1990-2005.
2. Abbruzzese JL, Abbruzzese MC, Lenzi R et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13 (8): 2094-2103.
3. Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 1988; 109 (5): 364-371.
4. Culine S, Kramar A, Saghatchian M et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002; 20 (24): 4679-4683.